Production of polyclonal antibody against Tehran strain influenza virus (A/H1N1/2009) hemagglutinin conserved domain (HA2): brief report
Background: The influenza virus is one of the most important factors for higher morbidity and mortality in the world. Recently, researchers have been focused on influenza conserved antigenic proteins such as hemagglutinin stalk domain (HA2) for vaccine production and serological studies. The HA2 pla...
Main Authors: | Somayeh Zamani, Fatemeh Fotouhi Chahouki, Zahra Nourmohammadi, Saeideh Sadeghi Neshat, Vahideh Mazaheri, Ali Torabi, Behrokh Farahmand |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tehran University of Medical Sciences
2015-10-01
|
Series: | Tehran University Medical Journal |
Subjects: | |
Online Access: | http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5377&slc_lang=en&sid=1 |
Similar Items
-
Purification of Influenza virus A (H1N1) recombinant Hemagglutinin (HA1) and polyclonal antibody production
by: Fateme Khosravi Node, et al.
Published: (2017-11-01) -
Cloning, expression and purification of hemagglutinin conserved domain (HA2) of influenza A virus, to be used in broad-spectrum subunit vaccine cocktails
by: B Farahmand, et al.
Published: (2017-05-01) -
Immunogenicity Enhancement of Influenza Virus Stalk Domain Using Leishmania Major Heat Shock Protein, One Step Closer to Universal Vaccine
by: Saeideh Sadeghi Neshat, et al.
Published: (2015-10-01) -
Design of Influenza Immunogens by Hemagglutinin (HA) Protein Minimization
by: Mallajosyula, V Vamsee Aditya
Published: (2018) -
POLYCLONAL ANTIBODIES AGAINST HUMAN PLASMINOGEN: PURIFICATION, CHARACTERIZATION AND APPLICATION
by: T. A. Yatsenko, et al.
Published: (2020-12-01)